DekaBank Deutsche Girozentrale decreased its stake in shares of Maximus, Inc. (NYSE:MMS – Get Rating) by 3.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 328,832 shares of the health services provider’s stock after selling 11,968 shares during the period. DekaBank Deutsche Girozentrale owned about 0.53% of Maximus worth $26,485,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Moors & Cabot Inc. purchased a new position in shares of Maximus during the third quarter valued at approximately $50,000. Exchange Traded Concepts LLC boosted its position in shares of Maximus by 50.0% during the fourth quarter. Exchange Traded Concepts LLC now owns 765 shares of the health services provider’s stock valued at $61,000 after buying an additional 255 shares during the last quarter. Fieldpoint Private Securities LLC boosted its position in shares of Maximus by 23.0% during the fourth quarter. Fieldpoint Private Securities LLC now owns 840 shares of the health services provider’s stock valued at $67,000 after buying an additional 157 shares during the last quarter. Van ECK Associates Corp boosted its position in shares of Maximus by 59.2% during the third quarter. Van ECK Associates Corp now owns 1,326 shares of the health services provider’s stock valued at $110,000 after buying an additional 493 shares during the last quarter. Finally, Eagle Bay Advisors LLC boosted its position in shares of Maximus by 51.4% during the third quarter. Eagle Bay Advisors LLC now owns 1,883 shares of the health services provider’s stock valued at $156,000 after buying an additional 639 shares during the last quarter. 93.54% of the stock is currently owned by institutional investors.
Shares of MMS traded up $0.52 during mid-day trading on Friday, hitting $74.96. The stock had a trading volume of 357,421 shares, compared to its average volume of 404,240. The firm has a market cap of $4.64 billion, a P/E ratio of 16.73 and a beta of 0.73. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.62 and a quick ratio of 1.62. The business has a fifty day moving average price of $75.83 and a 200-day moving average price of $79.10. Maximus, Inc. has a 52 week low of $72.04 and a 52 week high of $96.05.
The business also recently announced a quarterly dividend, which was paid on Monday, February 28th. Investors of record on Tuesday, February 15th were given a dividend of $0.28 per share. The ex-dividend date was Monday, February 14th. This represents a $1.12 annualized dividend and a yield of 1.49%. Maximus’s dividend payout ratio (DPR) is presently 25.00%.
MMS has been the topic of several research analyst reports. StockNews.com initiated coverage on Maximus in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Zacks Investment Research cut Maximus from a “strong-buy” rating to a “hold” rating and set a $86.00 price objective on the stock. in a research report on Thursday.
Maximus Profile (Get Rating)
MAXIMUS, Inc engages in the operation of government and human services programs. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers a variety of business process services, and appeals and assessments for state, provincial and national government programs.
Featured Articles
- Get a free copy of the StockNews.com research report on Maximus (MMS)
- 3 Recession-Proof Stocks to Buy Now
- MarketBeat: Week in Review 4/4 – 4/8
- 3 Best Life Sciences Stocks to Buy Now
- The Institutional Insiders Are Buying WD-40 Company
- What’s Behind The Latest Surge In GameStop (NYSE: GME)?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.